NCT06866366Completed
Retrospective, Multicenter, Single-arm, Observational Study, With Data From Patients With T2DM With Malnutrition or at Risk, Who Were Prescribed Resource® Diabet Plus as a Hypercaloric and Hyperproteic Specific Formula for Patients With T2DM
Impact of the Use of Resource® Diabet Plus on Metabolic Control in Patients With T2DM Who Are Malnourished or at Risk of Malnutrition
Source: ClinicalTrials.gov · Last updated 7 Oct 2025
Brief summary (registry, in English)
This retrospective multicentre study aims to provide real-world evidence of the effectiveness of Resource® Diabet Plus as supplementation tool for T2DM patients with malnutrition or at risk of malnutrition, under conditions of routine clinical practice in Spain.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 59 (actual)
- First submitted
- 4 Mar 2025
- Start date
- 23 Apr 2025
- Primary completion date
- 13 Jul 2025
- Lead sponsor
- Outcomes'10
- Diseases
- Type 2 diabetes
- NCT number
- NCT06866366
What you commit to
- Study type: Observational
- Participants enrolled: 59
- From 23 Apr 2025 to the primary completion date, 13 Jul 2025
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with severe renal insufficiency (glomerular filtration rate \< 30mL/min/1.73m2) at the time of selection.
Other
- Pregnant or breastfeeding women.
- Patients who required any other type of nutritional supplementation during the study period (parenteral/enteral).
Who the study is looking for
- Patients ≥ 18 years.
- Outpatients or hospitalised patients, at discharge with a diagnosis of type 2 Diabetes.
- Patients at risk of malnutrition detected by validated screening tools or with DRM diagnosed by GLIM criteria.
- Patients who have been prescribed 1-2 bottles/day of Resource® Diabet Plus following the conditions of use of its technical data sheet, in the last 2 years, with at least 24 weeks of evolution recorded in the clinical history.
- Patients who have Hb1Ac data in the medical record on the index date and during evolution.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario Insular de Gran Canaria Coordinator of this site? Confirm its status | Las Palmas de Gran Canaria | Spain | Unknown status |
| Hospital Clínico Universitario Virgen de la Arrixaca Coordinator of this site? Confirm its status | Murcia | Spain | Unknown status |
| Hospital Universitario Nuestra Señora de la Candelaria Coordinator of this site? Confirm its status | Santa Cruz de Tenerife | Spain | Unknown status |
| Hospital Universitario Virgen Macarena Coordinator of this site? Confirm its status | Seville | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.